Showing 681 - 700 results of 27,241 for search '(( 50 ((a decrease) OR (nn decrease)) ) OR ( 50 ((we decrease) OR (mean decrease)) ))', query time: 0.87s Refine Results
  1. 681

    Data Sheet 1_Reduced hemolytic complement activity in the classical pathway (CH50) is a risk factor for poor clinical outcomes of patients with infections: a retrospective analysis... by Hiroyuki Koami (3878434)

    Published 2025
    “…</p>Results<p>Of 2,726 patients who met the inclusion criteria, logistic regression models demonstrated that decreased CH50 is a significant predictor of 180-day mortality (OR: 0.98-0.99). …”
  2. 682
  3. 683

    Olaparib reverses the oxLDL-mediated decrease in co-immunoprecipitation of IκBα with RelA or p50. by Khamis Mustafa (17941332)

    Published 2024
    “…Relative band densities from three independent experiments were analyzed. (A) OxLDL decreased co-immunoprecipitation of IκBα with both RelA and p50, and olaparib reversed the effect of oxLDL on the dissociation of IκBα with RelA and p50. …”
  4. 684

    Effects of increasing temperature and, CO<sub>2</sub> on quality of litter, shredders, and microorganisms in Amazonian aquatic systems by Renato Tavares Martins (4634317)

    Published 2017
    “…We hypothesized that simulated climate change (warming and elevated CO<sub>2</sub>) would: i) decrease leaf-litter quality, ii) decrease survival and leaf breakdown by shredders, and iii) increase microbial leaf breakdown and fungal biomass. …”
  5. 685
  6. 686
  7. 687
  8. 688

    DataSheet1.docx by Rui Hong Guo (4963240)

    Published 2018
    “…We reported that V. vulnificus RtxA1 toxin caused acute cell death only when close contact to host cells was allowed. …”
  9. 689

    Decrease of NF-κB activity in tumor tissue of CCR5<sup>−/−</sup> mice. by Ju Kyoung Song (324058)

    Published 2013
    “…<b>C</b>, Immunolfluorescence analysis of p50 confirmed that the intensities of nuclear staining for p50 were decreased in the tumor tissues of CCR5<sup>−/−</sup> mice. …”
  10. 690
  11. 691
  12. 692
  13. 693
  14. 694

    AZP-531, an unacylated ghrelin analog, improves food-related behavior in patients with Prader-Willi syndrome: A randomized placebo-controlled trial by Soraya Allas (4752756)

    Published 2018
    “…AZP-531, a first-in-class UAG analog, was shown to inhibit the orexigenic effect of AG in animals, to improve glycemic control and decrease body weight in humans. …”
  15. 695
  16. 696
  17. 697
  18. 698
  19. 699
  20. 700